CClinicalTrials.gg
CompletedNCT04162912Updated Apr 17, 2020

Motivational Interviewing Tailored Programme for Promoting Advance Care Planning Behaviours

An interventional study of Motivational Interviewing tailored Advance Care Planning in End Stage Disease, sponsored by Food and Health Bureau, Hong Kong. Completed at 2 sites in Hong Kong. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-04-17.

Sponsored by Food and Health Bureau, Hong Kong · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 10 months after the study started (first participant enrolled Jan 2018, registered Nov 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
204
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This proposed study is designed to test the effects of motivational interviewing (MI) in increasing the uptake of ACP behaviours among patients with palliative care needs. A randomised controlled trial with repeated blinded outcome assessment will be conducted to assess the effects of a MI-tailored ACP (MI-ACP) programme on palliative care patients recruited from the outpatient palliative care clinics and home palliative care services of two hospitals. A total of 204 patients will be recruited and randomly assigned to experimental and control groups. The patients in the experimental group will receive a MI-ACP programme facilitated by a trained nurse, whereas the patients in the control group will receive usual care. Primary outcome is the behavioural changes in ACP. Secondary outcomes are perceived stress, decisional conflict and quality of life. Study outcomes will be measured at baseline, 1 month and 3 months after enrolment.

02

Conditions studied

  • End Stage Disease

Keywords

  • Advance Care Planning
  • Motivational Interviewing
  • Pallative Care
03

In context

Lead sponsor

Food and Health Bureau, Hong Kong is the lead sponsor of 6 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18 years of age or over
  • newly referred to palliative care services
  • with a palliative performance scale (PPS) score of 60 or above; and
  • with full level of consciousness

Exclusion criteria

Exclusion Criteria:

  • uncommunicable because of sensory impairment or language barrier
  • cognitively impaired
  • are receiving active psychiatric treatment
  • already had signed an advance directive
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
204 participants (actual)

Study arms

  • Experimental
    Experimental group

    Participants in the experimental group will receive a MotivationaI Interviewing tailored ACP programme.

    Behavioral: Motivational Interviewing tailored Advance Care Planning

  • No intervention
    Control group

    The participants in the control group will receive usual care offered by the palliative care team under study and its affiliated day care centres, home care team and outpatient clinics.

Interventions

  • BehavioralMotivational Interviewing tailored Advance Care Planning

    The trained interventionist who is experienced in MI techniques will explore their illness experiences, emotions and beliefs about their health conditions and future care in an empathetic manner and explore their ambivalence for ACP behaviours.

06

What researchers measure

Primary outcomes

  1. Advance Care Planning Behaviour

    Behaviour changes in ACP behaviours measured using a questionnaire. It included 4 items about different ACP behavior on a 5-point Likert scale. The higher score means the higher level of readiness for the behaviours.

    Time frame: Baseline, 1 month and 3 months follow up

Secondary outcomes

  1. Decisional conflict

    Decisional conflict regarding end-of-life care is measured by the SURE test, a questionnaire with 4-item on knowledge and support for medical decision making. The higher score means the less decisional conflict.

    Time frame: Baseline, 1 month and 3 months follow up

  2. Perceived stress

    Perceived stress is measured by a 10-item Perceived Stress Scale, a questionnaire, using a 5-point Likert scale. The higher score means the higher level of stress.

    Time frame: Baseline, 1 month and 3 months follow up

  3. Quality of life

    Quality of life is measured by using a 23-item modified Quality of Life Concerns in the End of Life Questionnaire. The 23 items are rated on a 4-point Likert scale. The higher score means the better quality of life.

    Time frame: Baseline, 1 month and 3 months follow up

07

Study locations

2 sites
  • United Christian Hospital
    Kwun Tong, Hong Kong
  • Haven of Hope Hospital
    Tseung Kwan O, Hong Kong
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 17, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04162912
Lead sponsor
Food and Health Bureau, Hong Kong
Collaborators
Haven of Hope Hospital, United Christian Hospital
Responsible party
Dr. Helen YL Chan (Associate Professor, Chinese University of Hong Kong) — Principal investigator
First posted
Nov 14, 2019
Start date
Jan 1, 2018
Primary completion
Dec 31, 2019
Completion
Dec 31, 2019
Last update
Apr 17, 2020

Study contacts

Helen N Chan, PhD
principal investigator · Chinese University of Hong Kong

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion